Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

EPA:AKE - Euronext Paris - Matif - FR0010313833 - Common Stock - Currency: EUR

82.8  -1.7 (-2.01%)

Fundamental Rating

5

Overall AKE gets a fundamental rating of 5 out of 10. We evaluated AKE against 63 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE scores decently on growth, while it is valued quite cheap. This could make an interesting combination. Finally AKE also has an excellent dividend rating. This makes AKE very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
In the past 5 years AKE has always been profitable.
AKE had a positive operating cash flow in each of the past 5 years.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

The Return On Assets of AKE (2.22%) is better than 65.08% of its industry peers.
The Return On Equity of AKE (4.49%) is better than 63.49% of its industry peers.
With a decent Return On Invested Capital value of 3.98%, AKE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 6.44%.
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROIC 3.98%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AKE has a Profit Margin of 3.54%. This is in the better half of the industry: AKE outperforms 65.08% of its industry peers.
In the last couple of years the Profit Margin of AKE has declined.
Looking at the Operating Margin, with a value of 7.52%, AKE is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
AKE's Operating Margin has declined in the last couple of years.
AKE's Gross Margin of 20.32% is on the low side compared to the rest of the industry. AKE is outperformed by 63.49% of its industry peers.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
Industry RankSector Rank
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
The number of shares outstanding for AKE has been increased compared to 1 year ago.
The number of shares outstanding for AKE has been reduced compared to 5 years ago.
Compared to 1 year ago, AKE has a worse debt to assets ratio.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AKE has an Altman-Z score of 1.90. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
AKE has a Altman-Z score (1.90) which is in line with its industry peers.
The Debt to FCF ratio of AKE is 12.65, which is on the high side as it means it would take AKE, 12.65 years of fcf income to pay off all of its debts.
AKE has a Debt to FCF ratio of 12.65. This is comparable to the rest of the industry: AKE outperforms 50.79% of its industry peers.
AKE has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.49, AKE is in line with its industry, outperforming 53.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Altman-Z 1.9
ROIC/WACC0.76
WACC5.25%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

AKE has a Current Ratio of 2.01. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.01, AKE is doing good in the industry, outperforming 68.25% of the companies in the same industry.
AKE has a Quick Ratio of 1.47. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
AKE has a Quick ratio of 1.47. This is in the better half of the industry: AKE outperforms 69.84% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.47
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for AKE have decreased by -5.86% in the last year.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.14% on average per year.
The Revenue has been growing slightly by 0.32% in the past year.
Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-5.86%
EPS 3Y-11.42%
EPS 5Y0.14%
EPS Q2Q%-9.29%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%3.88%

3.2 Future

Based on estimates for the next years, AKE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.10% on average per year.
Based on estimates for the next years, AKE will show a small growth in Revenue. The Revenue will grow by 4.36% on average per year.
EPS Next Y15.97%
EPS Next 2Y14.01%
EPS Next 3Y15.33%
EPS Next 5Y10.1%
Revenue Next Year5.03%
Revenue Next 2Y4.59%
Revenue Next 3Y4.21%
Revenue Next 5Y4.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.06, which indicates a very decent valuation of AKE.
AKE's Price/Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 95.24% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, AKE is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.68, the valuation of AKE can be described as reasonable.
AKE's Price/Forward Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 92.06% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (22.10), we can say AKE is valued rather cheaply.
Industry RankSector Rank
PE 10.06
Fwd PE 8.68
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKE is valued cheaper than 85.71% of the companies in the same industry.
AKE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKE is cheaper than 73.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.49
EV/EBITDA 5.79
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

AKE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AKE's earnings are expected to grow with 15.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.63
PEG (5Y)71.02
EPS Next 2Y14.01%
EPS Next 3Y15.33%

8

5. Dividend

5.1 Amount

AKE has a Yearly Dividend Yield of 4.26%, which is a nice return.
Compared to an average industry Dividend Yield of 3.09, AKE pays a better dividend. On top of this AKE pays more dividend than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.26%

5.2 History

On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years3
Div Non Decr Years3
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

77.22% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
AKE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP77.22%
EPS Next 2Y14.01%
EPS Next 3Y15.33%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (3/7/2025, 7:00:00 PM)

82.8

-1.7 (-2.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners52.1%
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap6.30B
Analysts81.82
Price Target106.53 (28.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.26%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP77.22%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.51%
Min EPS beat(2)-17.29%
Max EPS beat(2)-1.73%
EPS beat(4)2
Avg EPS beat(4)-0.41%
Min EPS beat(4)-17.29%
Max EPS beat(4)8.93%
EPS beat(8)5
Avg EPS beat(8)1.87%
EPS beat(12)9
Avg EPS beat(12)9.64%
EPS beat(16)13
Avg EPS beat(16)15.54%
Revenue beat(2)1
Avg Revenue beat(2)-0.68%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)3.26%
Revenue beat(8)3
Avg Revenue beat(8)-1.12%
Revenue beat(12)7
Avg Revenue beat(12)0.22%
Revenue beat(16)11
Avg Revenue beat(16)1.38%
PT rev (1m)-1.07%
PT rev (3m)-2.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.62%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-5.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.61%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE 10.06
Fwd PE 8.68
P/S 0.66
P/FCF 17.49
P/OCF 5.62
P/B 0.84
P/tB 3.02
EV/EBITDA 5.79
EPS(TTM)8.23
EY9.94%
EPS(NY)9.54
Fwd EY11.52%
FCF(TTM)4.73
FCFY5.72%
OCF(TTM)14.74
OCFY17.8%
SpS125.48
BVpS98.95
TBVpS27.37
PEG (NY)0.63
PEG (5Y)71.02
Profitability
Industry RankSector Rank
ROA 2.22%
ROE 4.49%
ROCE 5.64%
ROIC 3.98%
ROICexc 4.74%
ROICexgc 9.65%
OM 7.52%
PM (TTM) 3.54%
GM 20.32%
FCFM 3.77%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 12.65
Debt/EBITDA 2.42
Cap/Depr 94.89%
Cap/Sales 7.97%
Interest Coverage 44.88
Cash Conversion 73.75%
Profit Quality 106.51%
Current Ratio 2.01
Quick Ratio 1.47
Altman-Z 1.9
F-Score4
WACC5.25%
ROIC/WACC0.76
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.86%
EPS 3Y-11.42%
EPS 5Y0.14%
EPS Q2Q%-9.29%
EPS Next Y15.97%
EPS Next 2Y14.01%
EPS Next 3Y15.33%
EPS Next 5Y10.1%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%3.88%
Revenue Next Year5.03%
Revenue Next 2Y4.59%
Revenue Next 3Y4.21%
Revenue Next 5Y4.36%
EBIT growth 1Y-11.47%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year88.55%
EBIT Next 3Y30.59%
EBIT Next 5Y18.59%
FCF growth 1Y-39.39%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-11.87%
OCF growth 3Y7%
OCF growth 5Y-2.92%